Not a traditional drug phase: Communication for Nephrotic Syndrome in Children
NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matching with kidney patients and their physician investigators.
Official registry: https://clinicaltrials.gov/study/NCT04571658 · University of Michigan · enrollment listed as 375
What this phase means
This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
If you join, the listed intervention(s) are Communication. The registry lists allocation as na. NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matching with kidney patients and their physician investigators.
They plan to enroll about 375 people at 16 sites. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
Implementing Precision Medicine for Glomerular Diseases in the Nephrotic Syndrome Study Network (NEPTUNE)
Interventions: Communication
Primary outcome (registry wording): Matched participants with at least one clinical trial receive a MNB assessment
Who it is for (from inclusion criteria)
- Ages 1 Year to 80 Years
- Consented and eligible participants in the biopsied or non-biopsied cohorts of the NEPTUNE watch-and-measure (no experimental treatment required) study
- Must be potentially eligible for the NEPTUNE Match partnering trials (e.g. if no trial is enrolling a participant under age 6, those under 6 are not eligible)
- Note: NEPTUNE Match partnering trials and associated eligibility criteria are expected to be dynamic and change as trial protocols are developed, activated, and amended
- Regular nephrology healthcare provided at a NEPTUNE study site
- Willing and able to consent, and as appropriate assent, to participate in NEPTUNE Match
Who the registry excludes
- Currently non-NEPTUNE watch-and-measure (no experimental treatment required) study participants are not eligible to be matched to a clinical trial using these biomarker assessments
Public study contact (from the registry)
Hailey E Desmond, MS
Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.
Sites listed on ClinicalTrials.gov
16 listed- Emory University Hospital - Children's Hospital of Atlanta — Atlanta, Georgia (recruiting)
- John H. Stroger, Jr., Hospital of Cook County — Chicago, Illinois (recruiting)
- University of Kansas Medical Center — Kansas City, Kansas (recruiting)
- Johns Hopkins Medicine — Baltimore, Maryland (recruiting)
- University of Michigan — Ann Arbor, Michigan (enrolling_by_invitation)
- Children's Mercy Hospital — Kansas City, Missouri (recruiting)
- Northwell/Cohen's Children's Hospital — New Hyde Park, New York (recruiting)
- Columbia University Medical Center — New York, New York (recruiting)
- University of North Carolina Chapel Hill — Chapel Hill, North Carolina (recruiting)
- Cleveland Clinic Foundation — Cleveland, Ohio (recruiting)
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania (recruiting)
- Temple University — Philadelphia, Pennsylvania (recruiting)
FAQ about this NCT record
Is NCT04571658 still recruiting?
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT04571658?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT04571658?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.
How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary